Crescent Capital BDC Inc (CCAP)
Official siteFINANCIAL SERVICES • ASSET MANAGEMENT • NASDAQ
Market Cap: $371.41M
Last updated: Nov 17, 2026 at 4:15 PM ET
Crescent Capital BDC Inc (CCAP) Stock Chart
Crescent Capital BDC (CCAP) has a latest price of $9.88 on Nov 17, 2026, 26.4% below its 52-week high of $13.42. Its price fell 20.3% over the past 12 months. The month-end price fell 53.9% over the 5 years through Oct 2026, a compound annual decline of 14.3%.
Price Chart
From Feb 2020 to Oct 2026, its highest month-end close was $20.09 in Oct 2021 and its lowest $9.18 in Sep 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CCAP with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CCAP.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 4.7%, and over 6 months it fell 5.2%. The month-end price fell 40.4% over the 3 years through Oct 2026, a compound annual decline of 15.8%.
| Period | Change |
|---|---|
| 1 month | +13.6% |
| 3 months | -4.7% |
| 6 months | -5.2% |
| 12 months | -20.3% |
| 12 months, with dividends | -7.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -40.4% | -15.8% |
| 5 years | -53.9% | -14.3% |
Price by Year
Its best calendar year was 2023, when the price rose 36.0%, and its weakest was 2022, when it fell 27.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $9.27 | -34.0% |
| 2025 | $14.05 | -26.9% |
| 2024 | $19.22 | +10.6% |
| 2023 | $17.38 | +36.0% |
| 2022 | $12.78 | -27.4% |
| 2021 | $17.60 | +20.8% |
Trading Range
The price is 6.2% above its 50-day average of $9.30 and 9.5% below its 200-day average of $10.92.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $9.88 | |
| 52-week high | $13.42 | -26.4% |
| 52-week low | $8.39 | +17.8% |
| 50-day average | $9.30 | +6.2% |
| 200-day average | $10.92 | -9.5% |
Price Risk
Over 3 years, its largest fall from a peak was 48.7%.
| Measure | Value |
|---|---|
| 1-year beta | 0.55 |
| Largest fall, 1 year | -38.8% |
| Largest fall, 3 years | -48.7% |
Valuation
Crescent Capital BDC traded at 7.9x earnings at the end of 2025, against a 5-year median of 7.8x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CCAP
What is CCAP's 1-year price change?
Crescent Capital BDC's price fell 20.3% over the past 12 months. With dividends included, the 12-month total return was -7.3%.
What is CCAP's 5-year price change?
Crescent Capital BDC's month-end price fell 53.9% over the 5 years through Oct 2026, a compound annual decline of 14.3%. These figures leave out dividends.
What is CCAP's 52-week high and low?
Crescent Capital BDC's 52-week high is $13.42 and its 52-week low is $8.39. Its latest price of $9.88 on Nov 17, 2026 is 26.4% below the high.
What is CCAP's beta?
Crescent Capital BDC's 1-year beta against the S&P 500 is 0.55, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 38.8%.
Is the CCAP chart free?
Yes. Advanced Charting for CCAP is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CCAP pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors